Hongfei Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongfei Duan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hairong Huang
National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
2 shared publications - Jingyuan Feng
Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101125, China
1 shared publication - Ming Wang
Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, China, China
1 shared publication - Ming Wang
Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China
1 shared publication - Minghao Hu
Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101125, China
1 shared publication - Xia Yu
National Clinical Laboratory on Tuberculosis, Beijing Key laboratory for Drug-resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 16 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1561
Clinical Characteristics and Risk Factors for Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease
Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with concurrent CPA and NTM-PD. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex (OR 2.13, 95% CI: 1.03–4.47), dyspnea (OR 27.9, 95% CI: 4.24–570), cavity (OR 5.95, 95% CI: 2.76–13.9), use of oral corticosteroids (OR 4.28, 95% CI: 1.13–16.6), and interstitial lung disease (OR 15.5, 95% CI: 1.89–361). The wide confidence intervals for some risk factors reflect limited precision. The Kaplan–Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039). However, the adjusted hazard ratio was not statistically significant (HR 2.01, 95% CI: 0.66–6.12, p = 0.217). Conclusions: In patients with NTM-PD, the presence of concurrent CPA was associated with higher unadjusted mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.
- 16 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1561
Open AccessClinical Characteristics and Risk Factors for Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease
Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with concurrent CPA and NTM-PD. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex (OR 2.13, 95% CI: 1.03–4.47), dyspnea (OR 27.9, 95% CI: 4.24–570), cavity (OR 5.95, 95% CI: 2.76–13.9), use of oral corticosteroids (OR 4.28, 95% CI: 1.13–16.6), and interstitial lung disease (OR 15.5, 95% CI: 1.89–361). The wide confidence intervals for some risk factors reflect limited precision. The Kaplan–Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039). However, the adjusted hazard ratio was not statistically significant (HR 2.01, 95% CI: 0.66–6.12, p = 0.217). Conclusions: In patients with NTM-PD, the presence of concurrent CPA was associated with higher unadjusted mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.
- Open Access
- 7 January 2026
- Published by MDPI AG in Preprints.org
Clinical Characteristics and Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease with Chronic Pulmonary Aspergillosis in Patients
Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. Objective: This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with NTM-PD who were coinfected with CPA. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex(OR 2.13, 95% CI:1.03-4.47), dyspnea(OR 27.9, 95% CI:4.24-570), cavity(OR 5.95, 95% CI:2.76-13.9), use of oral corticosteroids(OR 4.28, 95% CI:1.13-16.6), and interstitial lung disease(OR 15.5, 95% CI:1.89-361). The Kaplan-Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039; HR 2.01, 95% CI:0.66-6.12). Conclusion: In patients with NTM-PD, the presence of concurrent CPA is associated with a marked increase in mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.
- 7 January 2026
- Published by MDPI AG in Preprints.org
Open AccessClinical Characteristics and Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease with Chronic Pulmonary Aspergillosis in Patients
Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. Objective: This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with NTM-PD who were coinfected with CPA. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex(OR 2.13, 95% CI:1.03-4.47), dyspnea(OR 27.9, 95% CI:4.24-570), cavity(OR 5.95, 95% CI:2.76-13.9), use of oral corticosteroids(OR 4.28, 95% CI:1.13-16.6), and interstitial lung disease(OR 15.5, 95% CI:1.89-361). The Kaplan-Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039; HR 2.01, 95% CI:0.66-6.12). Conclusion: In patients with NTM-PD, the presence of concurrent CPA is associated with a marked increase in mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.
- Open Access
- 28 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7639
Bidirectional Association Between Tuberculosis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Background: Tuberculosis (TB) and chronic obstructive pulmonary disease (COPD) are major respiratory diseases contributing to high global morbidity and mortality. Recent studies suggest a potential bidirectional association between them; however, the overall evidence has not been systematically integrated. This study aims to comprehensively evaluate the bidirectional epidemiological association between TB and COPD through a systematic review and meta-analysis. Methods: We systematically searched observational studies published from database inception to 31 August 2025, in PubMed, Embase, Web of Science, and other databases. Data were extracted from studies examining the risk of COPD development in individuals with a history of TB and the risk of TB development in COPD patients. Pooled effect sizes were calculated using random-effects models, including pooled odds ratios (ORs) and prevalence rates, with assessments of heterogeneity and publication bias. Results: A total of 32 studies were included, involving over 670,000 participants. Meta-analysis revealed that individuals with a history of TB had a significantly increased risk of developing COPD (pooled OR = 2.46, 95% CI: 1.95–3.10). Similarly, COPD patients had a significantly elevated risk of developing TB (pooled OR = 2.21, 95% CI: 1.57–3.11). The pooled prevalence of COPD among TB patients was 15.95% (95% CI: 11.61–21.53), while the pooled prevalence of TB among COPD patients was 5.57% (95% CI: 2.24–13.18). Significant heterogeneity was observed, but no substantial publication bias was detected. Conclusions: A significant and robust bidirectional association exists between TB and COPD, with each being an important independent risk factor for the other. These findings underscore the necessity of integrated screening and comorbidity management for both diseases in clinical practice and public health strategies, particularly in high TB burden regions. Prospective studies are warranted to further elucidate causal mechanisms and evaluate interventions.
- 28 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7639
Open AccessBidirectional Association Between Tuberculosis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Background: Tuberculosis (TB) and chronic obstructive pulmonary disease (COPD) are major respiratory diseases contributing to high global morbidity and mortality. Recent studies suggest a potential bidirectional association between them; however, the overall evidence has not been systematically integrated. This study aims to comprehensively evaluate the bidirectional epidemiological association between TB and COPD through a systematic review and meta-analysis. Methods: We systematically searched observational studies published from database inception to 31 August 2025, in PubMed, Embase, Web of Science, and other databases. Data were extracted from studies examining the risk of COPD development in individuals with a history of TB and the risk of TB development in COPD patients. Pooled effect sizes were calculated using random-effects models, including pooled odds ratios (ORs) and prevalence rates, with assessments of heterogeneity and publication bias. Results: A total of 32 studies were included, involving over 670,000 participants. Meta-analysis revealed that individuals with a history of TB had a significantly increased risk of developing COPD (pooled OR = 2.46, 95% CI: 1.95–3.10). Similarly, COPD patients had a significantly elevated risk of developing TB (pooled OR = 2.21, 95% CI: 1.57–3.11). The pooled prevalence of COPD among TB patients was 15.95% (95% CI: 11.61–21.53), while the pooled prevalence of TB among COPD patients was 5.57% (95% CI: 2.24–13.18). Significant heterogeneity was observed, but no substantial publication bias was detected. Conclusions: A significant and robust bidirectional association exists between TB and COPD, with each being an important independent risk factor for the other. These findings underscore the necessity of integrated screening and comorbidity management for both diseases in clinical practice and public health strategies, particularly in high TB burden regions. Prospective studies are warranted to further elucidate causal mechanisms and evaluate interventions.